Lu Chen
5PUBLICATIONS
65CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82.Susana S Najera, Christopher J Ricketts, Laura S Schmidt
|Nov 02, 2022
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.Katie E Hebron, Xiaolin Wan, Jacob S Roth
|Sep 01, 2018
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers.Paloma Del C Monroig-Bosque, Maitri Y Shah, Xiao Fu
|Jan 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.Ivan Vannini, Petra M Wise, Kishore B Challagundla
|Nov 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.Ivan Vannini, Petra M Wise, Kishore B Challagundla
Pageof 1
Frequent Collaborators
3 joint publications
Cristina Ivan
2 joint publications
Kishore B Challagundla
2 joint publications
Manuela Ferracin
2 joint publications
Maria Angelica Cortez
2 joint publications
Leng Han
2 joint publications
Han Liang
2 joint publications
William D Figg
2 joint publications
Simone Difilippantonio
2 joint publications
Cody J Peer
2 joint publications
Amy M James
